本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Krystal Biotech Inc.

338.75
+2.080.62%
成交量:28.09萬
成交額:9,516.70萬
市值:100.27億
市盈率:42.53
高:343.33
開:340.99
低:335.50
收:336.67
52周最高:382.54
52周最低:155.20
股本:2,959.88萬
流通股本:2,353.93萬
量比:1.22
換手率:1.19%
股息:- -
股息率:- -
每股收益(TTM):7.97
每股收益(LYR):6.84
淨資產收益率:20.12%
總資產收益率:9.37%
市淨率:7.38
市盈率(LYR):49.52

資料載入中...

2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/06

重要事件披露

Form 8-K - Current report
2023/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/07

重要事件披露

Form 8-K - Current report